Lpr and gld are single, recessive, autosomal genes which are non- complementary and which each induce similar syndromes of systemic autoimmunity and lymphoproliferation. The lpr gene has recently been determined to code for a defective form of the Fas apoptosis receptor, while the gld codes for a defective form of the Fas ligand. By using mixed cellular chimeras of congenic mouse strains, we have previously demonstrated that both the B cells and T cells in lpr mice express intrinsic abnormalities that are essential to the autoimmune syndrome. In parallel experiments with gld mice, we have found that in gld/+ mixed chimeras, the gld B cells do not show the striking preferential production of immunoglobulins and autoantibodies found in lpr/+ double chimeras, nor does lymphadenopathy occur. This indicates that the gld defect is extrinsic to the B cells that produce autoantibodies and the T cells that hyperaccumulate in this model. Further data have suggested that the Fas ligand may function in an autocrine manner as well. In the present application, we will determine the cellular source of the normal presumed Fas ligand that is supplied by the co-transferred +/+ bone marrow and determine the specificity of Fas/Fas ligand interaction.
The Specific Aims of the current proposal are: l) Does the expression of Fas ligand by B cells suppress gld disease? Although our preliminary data suggest that the answer to this question is """"""""no,"""""""" we have reservations regarding this conclusion. The proposed experiments will clarify this important issue. 2) What specific cell types produce the Fas ligand? The phenotype of the cells will clarify this important issue. 3) What is the specificity of the cells involved in Fas/Fas ligand interactions? If direct cell-cell communication is required (rather than the release of a soluble factor), we should be able to define the antigenic or receptor specificity of the Fas ligand bearing cell. 4)What cell populations express Fas ligand protein? An antibody to Fas ligand will be produced and use to detect cell-surface expression. These studies will thus help elucidate the in vivo functional effects of Fas/Fas ligand interactions in immunoregulation and tolerance induction. This understanding of the mechanism of action of the lpr and gld genetic defects will focus future research aimed at elucidating the causal mechanisms of human SLE.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
3R01AR040620-09S1
Application #
2739706
Study Section
Special Emphasis Panel (ZRG4 (01))
Project Start
1990-06-30
Project End
1999-03-31
Budget Start
1998-04-01
Budget End
1999-03-31
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Sekiguchi, Debora R; Jainandunsing, Sandra M; Fields, Michele L et al. (2002) Chronic graft-versus-host in Ig knockin transgenic mice abrogates B cell tolerance in anti-double-stranded DNA B cells. J Immunol 168:4142-53
Maldonado, M A; MacDonald, G C; Kakkanaiah, V N et al. (1999) Differential control of autoantibodies and lymphoproliferation by Fas ligand expression on CD4+ and CD8+ T cells in vivo. J Immunol 163:3138-42
Firestein, R; Feuerstein, N (1998) Association of activating transcription factor 2 (ATF2) with the ubiquitin-conjugating enzyme hUBC9. Implication of the ubiquitin/proteasome pathway in regulation of ATF2 in T cells. J Biol Chem 273:5892-902
Kakkanaiah, V N; Sobel, E S; MacDonald, G C et al. (1997) B cell genotype determines the fine specificity of autoantibody in lpr mice. J Immunol 159:1027-35
Creech, E A; Nakul-Aquaronne, D; Reap, E A et al. (1996) MHC genes modify systemic autoimmune disease. The role of the I-E locus. J Immunol 156:812-7
Kakkanaiah, V N; MacDonald, G C; Cohen, P L et al. (1996) Suppression and reversal of gld disease by parabiosis with normal mice. Clin Immunol Immunopathol 78:6-13
Reap, E A; Piecyk, M L; Oliver, A et al. (1996) Phenotypic abnormalities of splenic and bone marrow B cells in lpr and gld mice. Clin Immunol Immunopathol 78:21-9
Maldonado, M A; Eisenberg, R A; Roper, E et al. (1995) Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I. J Exp Med 181:641-8
Fossati, L; Sobel, E S; Iwamoto, M et al. (1995) The Yaa gene-mediated acceleration of murine lupus: Yaa- T cells from non-autoimmune mice collaborate with Yaa+ B cells to produce lupus autoantibodies in vivo. Eur J Immunol 25:3412-7
Reap, E A; Felix, N J; Wolthusen, P A et al. (1995) bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy. J Immunol 155:5455-62

Showing the most recent 10 out of 30 publications